David A Talan1, Darin J Saltzman2, William R Mower3, Anusha Krishnadasan4, Cecilia M Jude5, Ricky Amii4, Daniel A DeUgarte6, James X Wu7, Kavitha Pathmarajah4, Ashkan Morim4, Gregory J Moran8. 1. Department of Emergency Medicine, Olive View-UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Medicine, Division of Infectious Diseases, Olive View-UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. Electronic address: dtalan@ucla.edu. 2. Department of Surgery, Olive View-UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. 3. Department of Emergency Medicine, Ronald Reagan Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. 4. Department of Emergency Medicine, Olive View-UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. 5. Department of Radiology, Olive View-UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. 6. Division of Pediatric Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA. 7. Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA. 8. Department of Emergency Medicine, Olive View-UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Medicine, Division of Infectious Diseases, Olive View-UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Abstract
STUDY OBJECTIVE: Randomized trials suggest that nonoperative treatment of uncomplicated appendicitis with antibiotics-first is safe. No trial has evaluated outpatient treatment and no US randomized trial has been conducted, to our knowledge. This pilot study assessed feasibility of a multicenter US study comparing antibiotics-first, including outpatient management, with appendectomy. METHODS:Patients aged 5 years or older with uncomplicated appendicitis at 1 US hospital were randomized to appendectomy or intravenous ertapenem greater than or equal to 48 hours and oral cefdinir and metronidazole. Stable antibiotics-first-treated participants older than 13 years could be discharged after greater than or equal to 6-hour emergency department (ED) observation with next-day follow-up. Outcomes included 1-month major complication rate (primary) and hospital duration, pain, disability, quality of life, and hospital charges, and antibiotics-first appendectomy rate. RESULTS: Of 48 eligible patients, 30 (62.5%) consented, of whom 16 (53.3%) were randomized to antibiotics-first and 14 (46.7%) to appendectomy. Median age was 33 years (range 9 to 73 years), median WBC count was 15,000/μL (range 6,200 to 23,100/μL), and median computed tomography appendiceal diameter was 10 mm (range 7 to 18 mm). Of 15 antibiotic-treated adults, 14 (93.3%) were discharged from the ED and all had symptom resolution. At 1 month, major complications occurred in 2 appendectomy participants (14.3%; 95% confidence interval [CI] 1.8% to 42.8%) and 1 antibiotics-first participant (6.3%; 95% CI 0.2% to 30.2%). Antibiotics-first participants had less total hospital time than appendectomy participants, 16.2 versus 42.1 hours, respectively. Antibiotics-first-treated participants had less pain and disability. During median 12-month follow-up, 2 of 15 antibiotics-first-treated participants (13.3%; 95% CI 3.7% to 37.9%) developed appendicitis and 1 was treated successfully with antibiotics; 1 had appendectomy. No more major complications occurred in either group. CONCLUSION: A multicenter US trial comparing antibiotics-first to appendectomy, including outpatient management, is feasible to evaluate efficacy and safety.
RCT Entities:
STUDY OBJECTIVE: Randomized trials suggest that nonoperative treatment of uncomplicated appendicitis with antibiotics-first is safe. No trial has evaluated outpatient treatment and no US randomized trial has been conducted, to our knowledge. This pilot study assessed feasibility of a multicenter US study comparing antibiotics-first, including outpatient management, with appendectomy. METHODS:Patients aged 5 years or older with uncomplicated appendicitis at 1 US hospital were randomized to appendectomy or intravenous ertapenem greater than or equal to 48 hours and oral cefdinir and metronidazole. Stable antibiotics-first-treated participants older than 13 years could be discharged after greater than or equal to 6-hour emergency department (ED) observation with next-day follow-up. Outcomes included 1-month major complication rate (primary) and hospital duration, pain, disability, quality of life, and hospital charges, and antibiotics-first appendectomy rate. RESULTS: Of 48 eligible patients, 30 (62.5%) consented, of whom 16 (53.3%) were randomized to antibiotics-first and 14 (46.7%) to appendectomy. Median age was 33 years (range 9 to 73 years), median WBC count was 15,000/μL (range 6,200 to 23,100/μL), and median computed tomography appendiceal diameter was 10 mm (range 7 to 18 mm). Of 15 antibiotic-treated adults, 14 (93.3%) were discharged from the ED and all had symptom resolution. At 1 month, major complications occurred in 2 appendectomy participants (14.3%; 95% confidence interval [CI] 1.8% to 42.8%) and 1 antibiotics-first participant (6.3%; 95% CI 0.2% to 30.2%). Antibiotics-first participants had less total hospital time than appendectomy participants, 16.2 versus 42.1 hours, respectively. Antibiotics-first-treated participants had less pain and disability. During median 12-month follow-up, 2 of 15 antibiotics-first-treated participants (13.3%; 95% CI 3.7% to 37.9%) developed appendicitis and 1 was treated successfully with antibiotics; 1 had appendectomy. No more major complications occurred in either group. CONCLUSION: A multicenter US trial comparing antibiotics-first to appendectomy, including outpatient management, is feasible to evaluate efficacy and safety.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: David C Chang; Aki Shiozawa; Louis L Nguyen; Kristin L Chrouser; Bruce A Perler; Julie A Freischlag; Paul M Colombani; Fizan Abdullah Journal: J Am Coll Surg Date: 2010-11-30 Impact factor: 6.113
Authors: Lindsay A Bliss; Catherine J Yang; Tara S Kent; Sing Chau Ng; Jonathan F Critchlow; Jennifer F Tseng Journal: Surg Endosc Date: 2014-10-08 Impact factor: 4.584
Authors: Peter C Minneci; Justin B Mahida; Daniel L Lodwick; Jason P Sulkowski; Kristine M Nacion; Jennifer N Cooper; Erica J Ambeba; R Lawrence Moss; Katherine J Deans Journal: JAMA Surg Date: 2016-05-01 Impact factor: 14.766
Authors: Joseph S Solomkin; John E Mazuski; John S Bradley; Keith A Rodvold; Ellie J C Goldstein; Ellen J Baron; Patrick J O'Neill; Anthony W Chow; E Patchen Dellinger; Soumitra R Eachempati; Sherwood Gorbach; Mary Hilfiker; Addison K May; Avery B Nathens; Robert G Sawyer; John G Bartlett Journal: Clin Infect Dis Date: 2010-01-15 Impact factor: 9.079
Authors: Paulina Salminen; Risto Tuominen; Hannu Paajanen; Tero Rautio; Pia Nordström; Markku Aarnio; Tuomo Rantanen; Saija Hurme; Jukka-Pekka Mecklin; Juhani Sand; Johanna Virtanen; Airi Jartti; Juha M Grönroos Journal: JAMA Date: 2018-09-25 Impact factor: 56.272
Authors: Giana H Davidson; Sarah E Monsell; Heather Evans; Emily C Voldal; Erin Fannon; Sarah O Lawrence; Anusha Krishnadasan; David A Talan; Bonnie Bizzell; Patrick J Heagerty; Bryan A Comstock; Danielle C Lavallee; Cassandra Villegas; Robert Winchell; Callie M Thompson; Wesley H Self; Lillian S Kao; Shah-Jahan Dodwad; Amber K Sabbatini; David Droullard; David Machado-Aranda; Melinda Maggard Gibbons; Amy H Kaji; Daniel A DeUgarte; Lisa Ferrigno; Matthew Salzberg; Katherine A Mandell; Nicole Siparsky; Thea P Price; Anooradha Raman; Joshua Corsa; Jon Wisler; Patricia Ayoung-Chee; Jesse Victory; Alan Jones; Matthew Kutcher; Karen McGrane; Julie Holihan; Mike K Liang; Joseph Cuschieri; Jeffrey Johnson; Katherine Fischkoff; F Thurston Drake; Sabrina E Sanchez; Stephen R Odom; Larry G Kessler; David R Flum Journal: JAMA Surg Date: 2022-07-01 Impact factor: 16.681
Authors: David A Talan; Gregory J Moran; Anusha Krishnadasan; Sarah E Monsell; Brett A Faine; Lisandra Uribe; Amy H Kaji; Daniel A DeUgarte; Wesley H Self; Nathan I Shapiro; Joseph Cuschieri; Jacob Glaser; Pauline K Park; Thea P Price; Nicole Siparsky; Sabrina E Sanchez; David A Machado-Aranda; Jesse Victory; Patricia Ayoung-Chee; William Chiang; Joshua Corsa; Heather L Evans; Lisa Ferrigno; Luis Garcia; Quinton Hatch; Marc D Horton; Jeffrey Johnson; Alan Jones; Lillian S Kao; Anton Kelly; Daniel Kim; Matthew E Kutcher; Mike K Liang; Nima Maghami; Karen McGrane; Elizaveta Minko; Cassandra Mohr; Miriam Neufeld; Joe H Patton; Colin Rog; Amy Rushing; Amber K Sabbatini; Matthew Salzberg; Callie M Thompson; Aleksandr Tichter; Jon Wisler; Bonnie Bizzell; Erin Fannon; Sarah O Lawrence; Emily C Voldal; Danielle C Lavallee; Bryan A Comstock; Patrick J Heagerty; Giana H Davidson; David R Flum; Larry G Kessler Journal: JAMA Netw Open Date: 2022-07-01
Authors: Gaetano Poillucci; Lorenzo Mortola; Mauro Podda; Salomone Di Saverio; Laura Casula; Chiara Gerardi; Nicola Cillara; Luigi Presenti Journal: Updates Surg Date: 2017-11-03
Authors: Nigel J Hall; Frances C Sherratt; Simon Eaton; Isabel Reading; Erin Walker; Maria Chorozoglou; Lucy Beasant; Wendy Wood; Michael Stanton; Harriet J Corbett; Dean Rex; Natalie Hutchings; Elizabeth Dixon; Simon Grist; William Van't Hoff; Esther Crawley; Jane Blazeby; Bridget Young Journal: Health Technol Assess Date: 2021-02 Impact factor: 4.014
Authors: Suvi Sippola; Jussi Haijanen; Juha Grönroos; Tero Rautio; Pia Nordström; Tuomo Rantanen; Tarja Pinta; Imre Ilves; Anne Mattila; Jukka Rintala; Eliisa Löyttyniemi; Saija Hurme; Ville Tammilehto; Harri Marttila; Sanna Meriläinen; Johanna Laukkarinen; Eeva-Liisa Sävelä; Heini Savolainen; Tomi Sippola; Markku Aarnio; Hannu Paajanen; Paulina Salminen Journal: JAMA Date: 2021-01-26 Impact factor: 56.272